Skip to search formSkip to main contentSkip to account menu

IMM-101

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
e14627Background: The MODULATE (IMM-101-011, EUDRACT 2016-001459-28) trial recruits patients with metastatic or unresectable… 
2016
2016
Correction to: British Journal of Cancer (2016) 115, 789–796. doi:10.1038/bjc.2016.271 Upon publication of the above paper in the… 
2015
2015
Kidney disease is a complication that is observed in 10%?30% of patients infected with human immunodeficiency virus (HIV), and is… 
2014
2014
IMM-101 is an immunotherapeutic agent in clinical development as an adjunctive treatment in cancer. It comprises heat-killed… 
2013
2013
Pancreatic cancer is an aggressive cancer with poor prognosis. Despite its low incidence, it is the 4th cause of cancer-related… 
2013
2013
The tumour microenvironment is shaped by the interaction of tumour cells with a variety of “non” malignant cellular and acellular…